表紙
市場調查報告書

心臟切除裝置:醫療設備的開發平台評估

Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 654783
出版日期 內容資訊 英文 115 Pages
訂單完成後即時交付
價格
Back to Top
心臟切除裝置:醫療設備的開發平台評估 Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月18日內容資訊: 英文 115 Pages
簡介

本報告提供全球心臟切除裝置的市場上,主要開發中產品與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,及主要企業、組織的簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 心臟切除裝置概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 心臟切除裝置:臨床實驗中的開發中產品,各企業

  • 心臟切除裝置的企業:各臨床實驗階段的開發中產品
  • 心臟切除裝置:各臨床實驗階段的開發中產品

第5章 心臟切除裝置市場:企業、產品概要

  • AblaCor Medical Corporation
    • 開發中產品及進行中的臨床實驗概要
  • Adagio Medical Inc.
  • AFreeze GmbH
  • AngioDynamics Inc
  • AtriCure Inc
  • CPSI Biotech
  • Enigma Medical, Inc.
  • Helical Solutions, Inc. (Inactive)
  • Johns Hopkins University
  • Kardium Inc
  • LuxCath, LLC
  • Northwestern University
  • Sheba Medical Center
  • Spectranetics Corp
  • Thermedical Inc
  • Tufts Medical Center
  • University of California Los Angeles
  • University of Chicago
  • VytronUS, Inc.

第6章 心臟切除裝置市場:目前的趨勢 (共46件)

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0878EPD

GlobalData's Medical Devices sector report, "Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Ablation Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Ablation Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Ablation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Ablation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Cardiac Ablation Devices Overview 8

3 Products under Development 9

  • 3.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development 9
  • 3.2 Cardiac Ablation Devices - Pipeline Products by Territory 10
  • 3.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path 11
  • 3.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date 12
  • 3.5 Cardiac Ablation Devices - Ongoing Clinical Trials 13

4 Cardiac Ablation Devices - Pipeline Products under Development by Companies 14

  • 4.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development 14
  • 4.2 Cardiac Ablation Devices - Pipeline Products by Stage of Development 15

5 Cardiac Ablation Devices Companies and Product Overview 16

  • 5.1 AblaCor Medical Corporation Company Overview 16
    • 5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Adagio Medical Inc. Company Overview 18
    • 5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.3 AFreeze GmbH Company Overview 21
    • 5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 AngioDynamics Inc Company Overview 25
    • 5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.5 Atrian Medical Ltd Company Overview 26
    • 5.5.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.6 AtriCure Inc Company Overview 27
    • 5.6.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.7 Baylis Medical Company Inc Company Overview 32
    • 5.7.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.8 Corfigo Inc Company Overview 33
    • 5.8.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.9 Coridea, LLC Company Overview 34
    • 5.9.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.10 CPSI Biotech Company Overview 35
    • 5.10.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.11 Helical Solutions, Inc. (Inactive) Company Overview 39
    • 5.11.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.12 Johns Hopkins University Company Overview 40
    • 5.12.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.13 Kardium Inc Company Overview 42
    • 5.13.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.14 LuxCath, LLC Company Overview 43
    • 5.14.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.15 Medtronic plc Company Overview 44
    • 5.15.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.16 Northwestern University Company Overview 49
    • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.17 Sheba Medical Center Company Overview 50
    • 5.17.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.18 Spectranetics Corp Company Overview 51
    • 5.18.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.19 Thermedical Inc Company Overview 52
    • 5.19.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.20 Tufts Medical Center Company Overview 55
    • 5.20.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.21 University of California Los Angeles Company Overview 56
    • 5.21.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.22 University of Chicago Company Overview 57
    • 5.22.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.23 VytronUS Inc Company Overview 58
    • 5.23.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview 58

6 Cardiac Ablation Devices- Recent Developments 62

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 62
  • 6.2 Nov 18, 2019: Biosense Webster launches a two-pronged initiative to tackle the new millennium epidemic of Atrial Fibrillation 64
  • 6.3 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 65
  • 6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 66
  • 6.5 Nov 08, 2019: Stereotaxis and Catheter Precision combine robotic navigation and preoperative arrhythmia localization to treat cardiac arrhythmias 67

7 Appendix 112

  • 7.1 Methodology 112
  • 7.2 About GlobalData 115
  • 7.3 Contact Us 115
  • 7.4 Disclaimer 115

List of Tables

  • Table 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Table 2: Cardiac Ablation Devices - Pipeline Products by Territory
  • Table 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
  • Table 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
  • Table 5: Cardiac Ablation Devices - Ongoing Clinical Trials
  • Table 6: Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
  • Table 7: Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Table 8: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: AutoBlator - Product Status
  • Table 10: AutoBlator - Product Description
  • Table 11: CircumBlator AF Catheter Ablation System - Product Status
  • Table 12: CircumBlator AF Catheter Ablation System - Product Description
  • Table 13: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: iCLAS System - Product Status
  • Table 15: iCLAS System - Product Description
  • Table 16: Adagio Medical Inc. - Ongoing Clinical Trials Overview
  • Table 17: iCLAS System - A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients with Atrial Fibrillation
  • Table 18: iCLAS System - iCLAS for Persistent Atrial Fibrillation
  • Table 19: AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: CoolLoop - Product Status
  • Table 21: CoolLoop - Product Description
  • Table 22: Tip-Catheter - Product Status
  • Table 23: Tip-Catheter - Product Description
  • Table 24: AFreeze GmbH - Ongoing Clinical Trials Overview
  • Table 25: CoolLoop - Treatment Success with the CoolLoop Cryoablation System - Post-Market Surveillance
  • Table 26: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Non-Thermal Vein Ablation Device - Product Status
  • Table 28: Non-Thermal Vein Ablation Device - Product Description
  • Table 29: Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: mPEF Device - Atrial Fibrillation - Product Status
  • Table 31: mPEF Device - Atrial Fibrillation - Product Description
  • Table 32: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: AtriCure Bipolar System - Product Status
  • Table 34: AtriCure Bipolar System - Product Description
  • Table 35: cryoICE Ablation System - Atrial Fibrillation - Product Status
  • Table 36: cryoICE Ablation System - Atrial Fibrillation - Product Description
  • Table 37: AtriCure Inc - Ongoing Clinical Trials Overview
  • Table 38: AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
  • Table 39: cryoICE Ablation System - Atrial Fibrillation - AtriCure CryoIce Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery
  • Table 40: Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Cardiac Ablation Mitigating Device - Product Status
  • Table 42: Cardiac Ablation Mitigating Device - Product Description
  • Table 43: Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: HeArTPAD - Product Status
  • Table 45: HeArTPAD - Product Description
  • Table 46: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Cardiac Sympathetic Denervation Device - Product Status
  • Table 48: Cardiac Sympathetic Denervation Device - Product Description
  • Table 49: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: ICEolate Catheter - Product Status
  • Table 51: ICEolate Catheter - Product Description
  • Table 52: ICEolate Catheter With Spot Ablation Tip - Product Status
  • Table 53: ICEolate Catheter With Spot Ablation Tip - Product Description
  • Table 54: ICEolate Surgical Probe With Control Handle - Product Status
  • Table 55: ICEolate Surgical Probe With Control Handle - Product Description
  • Table 56: ICEolate Surgical Probe With Flexible Ablation Tip - Product Status
  • Table 57: ICEolate Surgical Probe With Flexible Ablation Tip - Product Description
  • Table 58: Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Catheter-Based Ablation Device - Product Status
  • Table 60: Catheter-Based Ablation Device - Product Description
  • Table 61: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Catheter Guiding Computational Modeling Tool - Product Status
  • Table 63: Catheter Guiding Computational Modeling Tool - Product Description
  • Table 64: Oscillatory Atherectomy Device - Product Status
  • Table 65: Oscillatory Atherectomy Device - Product Description
  • Table 66: Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Globe Mapping And Ablation System - Product Status
  • Table 68: Globe Mapping And Ablation System - Product Description
  • Table 69: LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Ablation Devices - Pipeline Products by Territory
  • Figure 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
  • Figure 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
  • Figure 5: Cardiac Ablation Devices - Ongoing Clinical Trials
Back to Top